Gsa Capital Partners LLP Invitae Corp Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $399,697 - $909,311	333,081 Added 1209.44%	360,621 $486,000
Q4 2022 Feb 13, 2023	SELL	$1.71 - $3.61 $99,082 - $209,174	-57,943 Reduced 67.78%	27,540 $51,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $162,417 - $737,718	85,483 New	85,483 $210,000
Q2 2020 Aug 11, 2020	SELL	$11.71 - $30.29 $152,721 - $395,042	-13,042 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$7.64 - $27.5 $64,000 - $230,367	-8,377 Reduced 39.11%	13,042 $178,000
Q4 2019 Feb 12, 2020	BUY	$15.02 - $20.57 $321,713 - $440,588	21,419 New	21,419 $345,000
Q4 2018 Feb 12, 2019	SELL	$9.26 - $16.38 $257,816 - $456,051	-27,842 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$7.54 - $18.31 $220,605 - $535,713	-29,258 Reduced 51.24%	27,842 $466,000
Q2 2018 Aug 09, 2018	BUY	$4.87 - $8.42 $278,077 - $480,782	57,100 New	57,100 $420,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.